NeuroMetrix, Inc. (NASDAQ:NURO) today announced that Quell will be one
of 30 companies to present their latest innovations at CES Unveiled New
York on November 10. CES Unveiled is produced by the Consumer
Electronics Association to provide a sneak peek at the year’s most
innovative products two months before CES® 2016. The event
will highlight innovation in health and fitness, automotive technology,
sports, smart home, virtual reality and more.
“CES is an important venue for companies launching and developing
consumer health technology brands,” said Frank McGillin, Senior VP and
General Manager of NeuroMetrix Consumer. “We are proud to have been
selected as one of four finalists for the 2015 Best of CES Award
in the health and fitness category. At CES Unveiled, we will share how
Quell is creating an entirely new category of wearables.”
About Quell Wearable Pain Relief Device
Quell is an easy-to-use, over-the-counter device for relief of chronic
pain. This wearable device utilizes NeuroMetrix's wearable intensive
nerve stimulation (WINS) technology to provide pain relief. In a recent
clinical study, Quell was shown to improve chronic pain and overall
health in 81% of participants. Quell is currently available through
select healthcare professionals, retailers, and online at www.QuellRelief.com.
About NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health Sciences
and Technology in 1996. For more information, please visit www.NeuroMetrix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151109006127/en/
Copyright Business Wire 2015